Givaudan SA Vs. Sarepta Therapeutics Industry Stock Comparison

Buy

83

GVDNY
Givaudan SA

Last Price:

$98.01

Seasonality Move:

4.23%

Buy

68

SRPT
Sarepta Therapeutics

Last Price:

$63.68

Seasonality Move:

16.21%

Buy

83

Givaudan SA (GVDNY) is a Buy

Is Givaudan SA a Buy, Sell or Hold?

The current Givaudan SA [GVDNY] share price is $97.60. The Score for GVDNY is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Buy

68

Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $63.51. The Score for SRPT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

The Givaudan SA share price today is $97.60

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVDNY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $63.51

The current trend is relatively stagnant and SRPT is experiencing slight selling pressure.

GVDNY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.09	Buy
Relative Strength Index (14 RSI):	67.71	Buy
Chaikin Money Flow:	2523	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(86.82 - 94.76)	Buy
Bollinger Bands (100):	(85.66 - 91.64)	Buy

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.05	Sell
Relative Strength Index (14 RSI):	49.01	Sell
Chaikin Money Flow:	-325446	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(53.12 - 63.24)	Buy
Bollinger Bands (100):	(71.35 - 124.31)	Sell

GVDNY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	94.65	Buy
20-day SMA:	91.73	Buy
50-day SMA:	90	Buy
200-day SMA:	93.33	Buy
8-day EMA:	95.11	Buy
20-day EMA:	92.75	Buy
50-day EMA:	90.62	Buy
200-day EMA:	90.35	Buy

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	61.59	Buy
20-day SMA:	56.86	Buy
50-day SMA:	76.27	Sell
200-day SMA:	113.9	Sell
8-day EMA:	61.31	Buy
20-day EMA:	61.63	Buy
50-day EMA:	73.93	Sell
200-day EMA:	103.71	Sell

Givaudan SA Earnings Growth & GVDNY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.

Givaudan SA Technical Analysis

	Apr 21	Apr 22	Apr 23	Apr 24	Apr 25	Apr 28	Apr 29	Apr 30	May 1	May 2
	Apr									May
	21	22	23	24	25	28	29	30	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Apr 21	Apr 22	Apr 23	Apr 24	Apr 25	Apr 28	Apr 29	Apr 30	May 1	May 2
	Apr									May
	21	22	23	24	25	28	29	30	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):